Cargando…
Proguanil and cycloguanil are organic cation transporter and multidrug and toxin extrusion substrates
BACKGROUND: Malaria, HIV/AIDS, and tuberculosis endemic areas show considerable geographical overlap, leading to incidence of co-infections. This requires treatment with multiple drugs, potentially causing adverse drug–drug interactions (DDIs). As anti-malarials are generally positively charged at p...
Autores principales: | van der Velden, Maarten, Bilos, Albert, van den Heuvel, Jeroen J. M. W., Rijpma, Sanna R., Hurkmans, Evelien G. E., Sauerwein, Robert W., Russel, Frans G. M., Koenderink, Jan B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5654082/ https://www.ncbi.nlm.nih.gov/pubmed/29061131 http://dx.doi.org/10.1186/s12936-017-2062-y |
Ejemplares similares
-
PfMDR2 and PfMDR5 are dispensable for Plasmodium falciparum asexual parasite multiplication but change in vitro susceptibility to anti-malarial drugs
por: van der Velden, Maarten, et al.
Publicado: (2015) -
Atovaquone and quinine anti-malarials inhibit ATP binding cassette transporter activity
por: Rijpma, Sanna R, et al.
Publicado: (2014) -
Human multidrug resistance protein 4 (MRP4) is a cellular efflux transporter for paracetamol glutathione and cysteine conjugates
por: Koenderink, Jan B., et al.
Publicado: (2020) -
Theoretical Investigation of the Enantioselective Complexations between pfDHFR and Cycloguanil Derivatives
por: Kulatee, Suriyawut, et al.
Publicado: (2017) -
Cycloguanil and Analogues Potently Target DHFR in Cancer Cells to Elicit Anti-Cancer Activity
por: Brown, Jennifer I., et al.
Publicado: (2023)